{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T03:06:17Z","timestamp":1784775977861,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>There is limited contemporary prospective real-world evidence of patients with chronic arterial disease in Latin America. The Network to control atherothrombosis (NEAT) registry is a national prospective observational study of patients with known coronary (CAD) and\/or peripheral arterial disease (PAD) in Brazil. A total of 2,005 patients were enrolled among 25 sites from September 2020 to March 2022. Patient characteristics, medications and laboratorial data were collected. Primary objective was to assess the proportion of patients who, at the initial visit, were in accordance with good medical practices (domains) for reducing cardiovascular risk in atherothrombotic disease. From the total of patients enrolled, 2 were excluded since they did not meet eligibility criteria. Among the 2,003 subjects included in the analysis, 55.6% had isolated CAD, 28.7% exclusive PAD and 15.7% had both diagnoses. Overall mean age was 66.3 (\u00b1\u200910.5) years and 65.7% were male patients. Regarding evidence-based therapies (EBTs), 4% were not using any antithrombotic drug and only 1.5% were using vascular dose of rivaroxaban (2.5\u00a0mg bid). Only 0.3% of the patients satisfied all the domains of secondary prevention, including prescription of EBTs and targets of body-mass index, blood pressure, LDL-cholesterol, and adherence of lifestyle recommendations. The main barrier for prescription of EBTs was medical judgement. Our findings highlight that the contemporary practice does not reflect a comprehensive approach for secondary prevention and had very low incorporation of new therapies in Brazil. Large-scale populational interventions addressing these gaps are warranted to improve the use of evidence-based therapies and reduce the burden of atherothrombotic disease.<\/jats:p><jats:p><jats:italic>ClinicalTrials.gov<\/jats:italic> NCT04677725<\/jats:p>","DOI":"10.1038\/s41598-024-54516-9","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T15:36:01Z","timestamp":1708443361000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Primary results of the brazilian registry of atherothrombotic disease (NEAT)"],"prefix":"10.1038","volume":"14","author":[{"given":"Pedro G. M.","family":"de Barros e Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlene Troiani","family":"do Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Pinto","family":"Pedrosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo Arruda","family":"Nakazone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel Ulloffo","family":"do Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leiliandry","family":"de Ara\u00fajo Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osvaldo Louren\u00e7o Silva","family":"J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9rgio Luiz","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Morel Vieira","family":"de Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo Reinaldo","family":"Bergo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalton Bertolim","family":"Precoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Tramujas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Gomes","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Miguel Malta","family":"Dantas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f4nio Cl\u00e1udio","family":"do Amaral Baruzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald Luiz Gomes","family":"Flumignan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Sanali Moura","family":"de Oliveira Paiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds Henrique Wolff","family":"Gowdak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscila Nasser","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Albuquerque","family":"de Figueiredo Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odilson Marcos","family":"Silvestre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Fioranelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo D.\u2019Oliveira","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Clara Peneluppi","family":"Horak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora Harumi Kodama","family":"Miyada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1via Cristina Soares","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00falia Souza","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"de Oliveira Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Pavanello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Ramacciotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato D.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the NEAT Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlene Troiani","family":"do Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Pinto","family":"Pedrosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo Arruda","family":"Nakazone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel Ulloffo","family":"do Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leiliandry","family":"de Ara\u00fajo Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osvaldo Louren\u00e7o Silva","family":"J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9rgio Luiz","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Morel Vieira","family":"de Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo Reinaldo","family":"Bergo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalton Bertolim","family":"Precoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Tramujas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Gomes","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Miguel Malta","family":"Dantas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f4nio Cl\u00e1udio","family":"do Amaral Baruzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald Luiz Gomes","family":"Flumignan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Sanali Moura","family":"de Oliveira Paiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds Henrique Wolff","family":"Gowdak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscila Nasser","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Albuquerque","family":"de Figueiredo Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odilson Marcos","family":"Silvestre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Fioranelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo D.\u2019Oliveira","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Augusto Ribas","family":"Fortes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Eduardo Fonteles","family":"Ritt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00facio R.","family":"Requi\u00e3o-Moura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabricio Assami","family":"Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Bernoche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio Antonio","family":"Pompilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,20]]},"reference":[{"issue":"3","key":"54516_CR1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/1358836X9800300309","volume":"3","author":"P Libby","year":"1998","unstructured":"Libby, P. The interface of atherosclerosis and thrombosis: Basic mechanisms. Vasc. Med. 3(3), 225\u2013229 (1998).","journal-title":"Vasc. Med."},{"issue":"9064","key":"54516_CR2","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/S0140-6736(96)07492-2","volume":"349","author":"CJ Murray","year":"1997","unstructured":"Murray, C. J. & Lopez, A. D. Alternative projections of mortality and disability by cause 1990\u20132020: Global Burden of Disease Study. Lancet. 349(9064), 1498\u20131504 (1997).","journal-title":"Lancet."},{"issue":"4","key":"54516_CR3","doi-asserted-by":"publisher","first-page":"78 e6","DOI":"10.1016\/j.ahj.2005.11.004","volume":"151","author":"EM Ohman","year":"2006","unstructured":"Ohman, E. M. et al. The reduction of atherothrombosis for continued health (REACH) registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design. Am Heart J 151(4), 78 e6\u201310 (2006).","journal-title":"Am Heart J"},{"issue":"2","key":"54516_CR4","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1001\/jama.295.2.180","volume":"295","author":"DL Bhatt","year":"2006","unstructured":"Bhatt, D. L. et al. REACH Registry Investigators International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 295(2), 180\u2013189 (2006).","journal-title":"JAMA."},{"issue":"34","key":"54516_CR5","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"FLJ Visseren","year":"2021","unstructured":"Visseren, F. L. J. et al. ESC National Cardiac Societies; ESC Scientific Document Group. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur. Heart J. 42(34), 3227\u20133337. https:\/\/doi.org\/10.1093\/eurheartj\/ehab484 (2021).","journal-title":"Eur. Heart J."},{"issue":"14","key":"54516_CR6","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","volume":"42","author":"JP Collet","year":"2021","unstructured":"Collet, J. P. et al. ESC Scientific Document Group. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur. Heart J. 42(14), 1289\u20131367. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa575 (2021).","journal-title":"Eur. Heart J."},{"issue":"3","key":"54516_CR7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","volume":"41","author":"J Knuuti","year":"2020","unstructured":"Knuuti, J. et al. ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur. Heart J. 41(3), 407\u2013477. https:\/\/doi.org\/10.1093\/eurheartj\/ehz425 (2020).","journal-title":"Eur. Heart J."},{"issue":"12","key":"54516_CR8","doi-asserted-by":"publisher","first-page":"e686","DOI":"10.1161\/CIR.0000000000000470","volume":"135","author":"MD Gerhard-Herman","year":"2017","unstructured":"Gerhard-Herman, M. D. et al. 2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 135(12), e686\u2013e725. https:\/\/doi.org\/10.1161\/CIR.0000000000000470 (2017).","journal-title":"Circulation."},{"issue":"10226","key":"54516_CR9","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S0140-6736(19)32008-2","volume":"395","author":"S Yusuf","year":"2020","unstructured":"Yusuf, S. et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): A prospective cohort study. Lancet. 395(10226), 795\u2013808. https:\/\/doi.org\/10.1016\/S0140-6736(19)32008-2 (2020).","journal-title":"Lancet."},{"issue":"3","key":"54516_CR10","doi-asserted-by":"publisher","first-page":"212","DOI":"10.5935\/abc.20130062","volume":"100","author":"O Berwanger","year":"2013","unstructured":"Berwanger, O. et al. Evidence-based therapy prescription in high-cardiovascular risk patients: the REACT study. Arquivos Brasileiros de Cardiologia. 100(3), 212\u2013220 (2013).","journal-title":"Arquivos Brasileiros de Cardiologia."},{"issue":"2","key":"54516_CR11","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/eurheartj\/ehv437","volume":"37","author":"M Komajda","year":"2016","unstructured":"Komajda, M. et al. EURObservational research programme: The Chronic Ischaemic Cardiovascular Disease Registry: Pilot phase (CICD-PILOT). Eur. Heart J. 37(2), 152\u2013160. https:\/\/doi.org\/10.1093\/eurheartj\/ehv437 (2016).","journal-title":"Eur. Heart J."},{"issue":"1","key":"54516_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2020-001803","volume":"9","author":"KKW Olesen","year":"2021","unstructured":"Olesen, K. K. W., Gyldenkerne, C., Thim, T., Thomsen, R. W. & Maeng, M. Peripheral artery disease, lower limb revascularization, and amputation in diabetes patients with and without coronary artery disease: A cohort study from the Western Denmark Heart Registry. BMJ Open Diabetes Res. Care. 9(1), e001803. https:\/\/doi.org\/10.1136\/bmjdrc-2020-001803 (2021).","journal-title":"BMJ Open Diabetes Res. Care."},{"key":"54516_CR13","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","volume":"377","author":"JW Eikelboom","year":"2017","unstructured":"Eikelboom, J. W. et al. Rivaroxaban with or without aspirin in stable cardiovascular disease. N. Engl. J. Med. 377, 1319\u20131330 (2017).","journal-title":"N. Engl. J. Med."},{"key":"54516_CR14","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","volume":"382","author":"MP Bonaca","year":"2020","unstructured":"Bonaca, M. P. et al. Rivaroxaban in peripheral artery disease after revascularization. N. Engl. J. Med. 382, 1994\u20132004 (2020).","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"54516_CR15","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/s41569-021-00663-9","volume":"19","author":"J Golledge","year":"2022","unstructured":"Golledge, J. Update on the pathophysiology and medical treatment of peripheral artery disease. Nat. Rev. Cardiol. 19(7), 456\u2013474. https:\/\/doi.org\/10.1038\/s41569-021-00663-9 (2022).","journal-title":"Nat. Rev. Cardiol."},{"key":"54516_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/9781118162934","volume-title":"Sampling","author":"SK Thompson","year":"2012","unstructured":"Thompson, S. K. Sampling 3rd edn. (Wiley, 2012).","edition":"3"},{"key":"54516_CR17","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1161\/CIRCULATIONAHA.109.192703","volume":"121","author":"DM Lloyd-Jones","year":"2010","unstructured":"Lloyd-Jones, D. M. et al. Defining and setting national goals for cardiovascular health promotion and disease reduction the American Heart Association\u2019s strategic impact goal through 2020. Circulation 121, 586\u2013613 (2010).","journal-title":"Circulation"},{"issue":"138","key":"54516_CR18","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.amjcard.2020.10.019","volume":"1","author":"ATH Nguyen","year":"2021","unstructured":"Nguyen, A. T. H. et al. Usefulness of the American Heart Association\u2019s ideal cardiovascular health measure to predict long-term major adverse cardiovascular events (from the heart SCORE study). Am. J. Cardiol. 1(138), 20\u201325. https:\/\/doi.org\/10.1016\/j.amjcard.2020.10.019 (2021).","journal-title":"Am. J. Cardiol."},{"issue":"8","key":"54516_CR19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/clc.22005","volume":"35","author":"C Cant\u00fa-Brito","year":"2012","unstructured":"Cant\u00fa-Brito, C. et al. Atherothrombotic disease, traditional risk factors, and 4-year mortality in a Latin American population: The REACH Registry. Clin. Cardiol. 35(8), 451\u2013457 (2012).","journal-title":"Clin. Cardiol."},{"issue":"1","key":"54516_CR20","doi-asserted-by":"publisher","first-page":"108","DOI":"10.36660\/abc.20190885","volume":"116","author":"PGMBE Silva","year":"2021","unstructured":"Silva, P. G. M. B. E. et al. Evaluation of 1-year follow-up of patients included in the registry of clinical practice in patients at high cardiovascular risk (REACT). Arq. Bras. Cardiol. 116(1), 108\u2013116. https:\/\/doi.org\/10.36660\/abc.20190885 (2021).","journal-title":"Arq. Bras. Cardiol."},{"key":"54516_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ijcard.2018.05.102","volume":"267","author":"PGM de Barros e Silva","year":"2018","unstructured":"de Barros e Silva, P. G. M. et al. Improvement in quality indicators using NCDR\u00ae registries: first international experience. Int. J. Cardiol. 267, 13\u201315 (2018).","journal-title":"Int. J. Cardiol."},{"issue":"5","key":"54516_CR22","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1001\/jamacardio.2019.0649","volume":"4","author":"MJ Machline-Carrion","year":"2019","unstructured":"Machline-Carrion, M. J. et al. BRIDGE Cardiovascular Prevention Investigators. Effect of a multifaceted quality improvement intervention on the prescription of evidence-based treatment in patients at high cardiovascular risk in Brazil: The BRIDGE cardiovascular prevention cluster rando. JAMA Cardiol. 4(5), 408\u2013417. https:\/\/doi.org\/10.1001\/jamacardio.2019.0649 (2019).","journal-title":"JAMA Cardiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-54516-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-54516-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-54516-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T15:39:48Z","timestamp":1708443588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-54516-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,20]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["54516"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-54516-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,20]]},"assertion":[{"value":"12 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"PGMBS reports fees and research grants from Pfizer, Roche Diagnostics and Bayer. RDL reports research support from Bristol-Myers Squibb, GlaxoSmithKline, Medtronic, Pfizer; Consulting fees from Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi-Sankyo, GlaxoSmithKline, Medtronic, Merck, Pfizer, Portola. All other co-authors report no conflicts of interest (conflict of interest: none declared).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4222"}}